Nippon India Pharma Fund - Direct (G) vs Tata Arbitrage Fund - Direct (G)

Nippon India Pharma Fund - Direct (G) vs Tata Arbitrage Fund - Direct (G)

stock1

Nippon India Pharma Fund - Direct (G)

7.4%

stock2

Tata Arbitrage Fund - Direct (G)

6.63%

Loading chart...

About Fund

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Deutsche Bank HDFC CitiBank N.A. Standard Chartered Bank

CAMS Ltd. Karvy Computershare P Ltd MCS Ltd.

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

Low Risk

5000

24026.00

0.98

16.2018

December 10, 2018

0.25

14.01 %

19.35 %

7.4 %

6.74 %

7.62 %

6.63 %

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Sailesh Jain

B.Com, MBA,

He is having 3 years of experience in Derivative Sales. He started his career with Refco - Sify Securities India Ltd.He worked also with Brics Securities Ltd.

Get your FAQs right